Bacterial cell fate under stress: lipid remodeling and antimicrobial peptide attack.
LL-37 just picked up a win in the fight against bacterial stress responses. Researchers at the University of Graz put this well-known antimicrobial peptide through its paces, testing how it handles bacteria that remodel their membranes under stress. Bacteria often shift their lipid makeup when threatened, which can throw off traditional treatments. The question: can peptide-based approaches like LL-37 still get the job done?
NPJ Antimicrob Resist
by Vejzovic D, Schwaiger T, Topciu A et al.
“Bacterial cell fate under stress: lipid remodeling and antimicrobial peptide attack. Vejzovic D(1), Schwaiger T(2), Topciu A(2), Petrowitsch L(2), Arnautovic A(2), Malanovic N(3)(4)(5). Author information: (1)Institute of Molecular Biosciences, University of Graz, Graz, Austria. djenana.vejzovic@medunigraz.at. (2)Institute of Molecular Biosciences, University of Graz, Graz, Austria. (3)Institute of Molecular Biosciences, University of Graz, Graz, Austria. nermina.malanovic@uni-graz.at. (4)Field of Excellence BioHealth, University of Graz, Graz, Austria. nermina.malanovic@uni-graz.at. (5)BioTechMed-Graz, Graz, Austria. nermina.malanovic@uni-graz.at. Dynamic changes in lipid membrane composition are a common response to stress, often involving shifts in key lipid molecules. Phosphatidic acid (PA), a central precursor in lipid biosynthesis, accumulates when anionic phospholipid synthesis is blocked-lipids that are typically primary targets of membrane-active antimicrobial peptides (AMPs). This raises the question of how cationic AMPs adapt to such lipid remodeling, which is especially relevant given their promise as novel therapeutics against escalating antimicrobial resistance. Their killing mechanism is often unclear. To identify ongoing processes clearly linked to bacterial cell death, six assays targeting membrane integrity and cell viability were performed alongside bactericidal measurements. These assays were conducted on Escherichia coli and a mutant depleted of anionic phospholipids, treated with the cationic peptides melittin and LL-37. Correlation of assays generated characteristic antimicrobial profiles, providing insight into the peptides' mechanisms. LL-37 acted independently of membrane composition, while melittin showed increased activity in the absence of anionic phospholipids. This study confirmed specific interactions with PA, but their action suggests targets beyond the membrane, as bacteria remained viable during membrane disruption but failed to form colonies. Overall, these findings indicate that both peptides can effectively handle lipid remodeling and uncover processes driving bacterial cell death. © 2026. The Author(s). Conflict of interest statement: Competing interests: The authors declare no competing interests.”
The team used E. coli, including a mutant with a tweaked membrane lacking the usual anionic phospholipids. These are prime targets for many antimicrobial peptides. They hit the bacteria with LL-37 and melittin, then ran six separate assays to track what actually happens inside those cells—membrane integrity, cell viability, and how many bacteria survived to form colonies.
What stood out? LL-37 didn’t care about the membrane composition. It killed off E. coli regardless of whether those anionic phospholipids were present. Melittin, on the other hand, actually worked better when those lipids were missing. Both peptides interacted with phosphatidic acid—a major lipid that accumulates during membrane stress—but the real action seems to happen beyond just the membrane. Even when the cell wall got wrecked, some bacteria looked intact but couldn’t form new colonies. This hints that the peptides’ real kill switch sits deeper inside the cell.
Key takeaway: LL-37 adapts to bacterial lipid remodeling, making it a flexible research tool for tackling antimicrobial resistance. Melittin’s variable effect opens questions about how different peptides leverage these stress responses.
If you’re studying antimicrobial peptides, these results spotlight why LL-37 deserves a spot in your research lineup. Get the details or source LL-37 from a trusted vendor. For more on LL-37, check out our ll-37 page.
Bacteria keep trying new tricks, but the peptide toolbox keeps catching up.
Related Reading
Eu(3+)-mediated dual-crosslinked collagen-mimetic peptide/sodium alginate hydrogel for 3D-printed skin wound dressings.
News · Acta BiomaterAntimicrobial-potentiated colorectal cancer therapy with synchronized tumoricidal immunity via a self-deliverable nanopeptide.
News · J Am Pharm Assoc (2003)Real-world weight impact upon tirzepatide discontinuation at a single-center endocrinology clinic in patients with overweight or obesity.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.